search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
OPERATING ROOM


healthcare organizations, by and large, improved their decontami- nation once the pandemic hit.


“[Before] the pandemic, healthcare facilities primarily utilized acute room decontamination in rooms where a highly contagious infection (e.g., C. diff) had been identified or in high-traffic and high-risk environ- ments (e.g., operating rooms),” he observed. “Since COVID-19, healthcare facilities have elevated their standards for disinfection by utilizing whole room disinfection systems to kill pathogens in a greater number of areas across facilities. For instance, the Halo Disinfection System, which combines the H2O2-based HaloMist (EPA Reg. No. 84526-6) disinfectant with the HaloFogger dry fogger, was trusted by hospitals worldwide for its flexibility and efficacy in eliminating -oV- pathogens, the virus that causes COVID-19. “s healthcare facilities look to the future, they should ensure the disinfection products they utilize are registered by the EPA and approved to use against some of the most challenging pathogens to kill,” t. lair continued. “ ist , products with sporicidal kill claims against  difficie, and  ist , products that meet criteria for use against SARS-CoV-2, are two EPA resources to consider when looking for an approved solution.” Richard Hayes, President, UVDI, highlights progressive development in UV-C use. “During the pandemic, more hospitals deployed UV-C room disinfection more broadly than previ- ously,” he noted, “not ust for outbreaks or terminal disinfection of isolation rooms, but for everyday


David St. Clair Richard Hayes


use in and beyond critical areas. Proven UV-C devices with inde- pendently verified pathogen inactivation claims via third-party laboratory testing and peer-reviewed published studies, enhance environmental hygiene as a complement to manual cleaners and disinfectants. Additionally, the broader focus on the entire environ- mental – both surface and air protection – has led to widespread implementation of proven UV-C air disinfection technologies to help prevent airborne pathogen transmission.” These efforts shouldn’t come as a surprise, according to Halden Shane, DPM, Chairman & CEO, TOMI Environmental Solutions Inc.


“The pandemic showcased how pathogens can easily spread and


take hold, highlighting the need for an increased level of disinfec- tion and decontamination to maintain a healthy environment and reduce cross contamination,” Shane noted. “Adding an advanced disinfection to your current facility cleaning protocols is paramount to ensure pathogens no longer exist in any area and provide a peace of mind to patients, staff and visitors.” Healthcare workers learned fairly quickly during the pandemic


that they needed to escalate their cleaning and disinfection practices, according to eva ea, .., , linical cience iaison, . “This involved increas ing usage of traditional chemical disinfectants such as bleach, quaternary ammonium, quaternary ammoniumalcohols, hydrogen peroxide, etc.,” she noted. “But it became quite clear early on that traditional cleaning and disinfection may not be enough. Therefore, many facilities opted to adopt improved disinfection strategies that involved ‘no touch’ technologies.


Deva Rea Page 18


Raising the Standard for Whole Room bvbm=;1ঞom


;-Ѵ|_1-u; -m7 1ollmb|Ŋ-1tbu;7 bm=;1ঞomv Ѵbh; ĸ 7bL1bѲ;Ķ ĸ -ubvĶ (


-ѴovbѴĽv -Ѵo bv|Ť 7bvbm=;1|-m| Ő !;] ŊƐƖķ -m7 lou;ķ -u; - mb;uv-Ѵ 1om1;um =ou |o7-Ľv 0v _;-Ѵ|_1-u;


=-1bѴbঞ;v )_bѴ; vru-Ŋ-m7Ŋbr; -m7 &(Ŋ0-v;7 vv|;lv ;u-7b1-|; l-m buv;vķ |_; o[;m lbvv r-|_o];mv bm _-u7Ŋ|oŊu;-1_ -u;-v 7u =o]]bm]


o ѶƓƔƑѵŊѵő ;Ѵblbm-|;v


r-|_o];mv om _-u7ķ momŊrouov vu=-1;v b|_ mo u;vb7;ķ achieving the _b]_;v| v|-m7-u7 =ou ;L1-1ķ v-=;| -m7 -@ou7-0bѴb| om |_; l-uh;| |o7-


"Ѵo |_; vru;-7 o= bm=;1ঞom bm ou _;-Ѵ|_1-u; =-1bѴb| om|-1|


$;Ѵĺ +1 302.454.8102 |


-ѴovbѴ -| halosil.com/shadow |o rѴ-1; -m ou7;u l-bѴĺ info@halosil.com


18 September 2021 • HEALTHCARE PURCHASING NEWS • hpnonline.com 2109HPN_HalosilInternational.indd 1


8/11/21 11:31 AM


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54